目的用模拟人卵巢癌抗原并有满意免疫原性的抗独特型微抗体进行临床前动物实验研究。
An anti-idiotypic mini body with optimal antigenicity which mimicking ovarian cancer antigen was used for therapeutic research in mice model bearing ovarian cancer.
为了降低人抗鼠抗体反应，获得满意的免疫原性，将模拟人卵巢癌抗原的抗独特型单链抗体人源化。
In order to reduce the human anti mouse antibody response and obtain optimal antigenicity, anti idiotype single chain which mimicking ovarian cancer antigen has been humanized.
目的评价组织多肽抗原(TPA)在卵巢癌诊断和监测中的临床价值。
Objective to evaluate the clinical usefulness of tissue polypeptide antigen (TPA) in diagnosis and monitoring the course of patients with ovarian carcinoma.
目的：探讨卵巢癌中HLA - DR抗原表达和树突细胞浸润的情况及其意义。
Objective: To investigate the clinical and immunological significance of HLA-DR antigen expression and dendritic cell infiltration in epithelial ovarian cancer.
目的探讨HLA抗原与宫颈癌、卵巢癌病因学中发病风险的关系。
Objective: To study the association between the human leukocyte antigen(HLA) and the risk of cervical carcinoma and ovarian carcinoma.
目的：研究血浆组织因子途径抑制物（TF PI） 抗原含量及活性对卵巢癌患者的临床意义。
Objective To study the clinical value of the quantities and the activity of tissue factor pathway inhibitor (TFPI) in ovarian cancer.
CA125卵巢癌相关抗原发现于1981年。
CA125卵巢癌相关抗原发现于1981年。
应用推荐